SOD1 and pulmonary fibrosis: Previous works have reported an increase in antioxidant enzyme activities, such as SOD and catalase, during SARS-CoV2 infection [113,114], and animal studies have shown that the use of a synthetic and stable SOD has a protective effect in pulmonary fibrosis, lung inflammation, and ARDS [115,116,117].